Japan· JP-3999412G7020
エポエチンアルファ（遺伝子組換え）
A medicinal product containing エポエチンアルファ（遺伝子組換え）, registered in Japan by 協和キリン, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- エポエチンアルファ（遺伝子組換え）
- Manufacturer
- 協和キリン
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
エポエチンアルファ（遺伝子組換え） in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaABSEAMEDMedice Arzneimittel Pütter GmbH & Co. KG, Iserlohn
- FinlandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG
- BelgiumAbseamed 1000 IU/0.5 mlMedice Arzneimittel Pütter
- IcelandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG*
- NetherlandsAbseamed 10.000 IE/1 ml oplossing voor injectie in een voorgevulde spuitMedice Arzneimittel Pütter GmbH & Co. KG
- SwedenAbseamed 10 000 IE/ 1 ml Injektionsvätska, lösning i förfylld sprutaMedice Arzneimittel Pütter GmbH & Co. KG
- PolandAbseamedMedice Arzneimittel Puetter GmbH & Co. KG
- IrelandAbseamed 1 000 IU/0.5 mL solution for injection in a pre-filled syringeMedice Arzneimittel Putter GmbH & Co. K.G
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Erypo
- Belgium · Eprex
- Czechia · Eprex
- Germany · Erypo Fs
- Spain · Eprex
- France · Eprex
- United Kingdom (Northern Ireland) · Eprex
- Greece · Eprex
- Iceland · Abseamed, Binocrit
- Italy · Eprex
- Liechtenstein · Binocrit, Epoetin Alfa Hexal
- Luxembourg · Eprex
- Netherlands · Eprex
- Norway · Abseamed, Binocrit
- Portugal · Eprex
- Slovenia · Eprex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1fa0bb97-7886-4090-a699-908fad6b09f2 GET /v1/drugs/1fa0bb97-7886-4090-a699-908fad6b09f2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２４，０００国際単位０．５ｍＬ１筒",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999412G7020",
"category": "注射薬",
"price_yen": 10898,
"generic_name": "エポエチンアルファ（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about エポエチンアルファ（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.